Amcare Biosciences

Our Products

TEMPERATE-SPAS Suspension | Composition & Product Details

Temperate®SPAS

Product Composition

Manufacturer of Each 5 ml contains:- Dicyclomine Hcl 10 mg Paracetamol IP 125 mg

Packaging Details

60 ml

Product Description

TEMPERATE-SPAS Suspension – Complete Product Information

1. Product Overview

TEMPERATE-SPAS Suspension is a combination oral suspension containing Dicyclomine Hydrochloride and Paracetamol. As shown in the supplied product artwork, the formulation combines an antispasmodic agent with an analgesic and antipyretic medicine. Dicyclomine Hydrochloride helps relieve smooth muscle spasms in the gastrointestinal tract, while Paracetamol helps relieve pain and reduce elevated body temperature.

The product is presented in a strawberry-flavoured syrup base. Its liquid dosage form is intended for oral administration when a healthcare professional determines that the combination is appropriate for the patient’s condition.

Dicyclomine Hydrochloride belongs to the anticholinergic class of medicines. It acts primarily by reducing smooth muscle spasms in the gastrointestinal tract. Paracetamol, also known as acetaminophen, is an analgesic and antipyretic medicine that helps reduce pain and fever through mechanisms that differ from those of Dicyclomine.

The combination requires particular caution in paediatric patients. Dicyclomine has important age-related restrictions and should not be used in infants younger than six months. The suitability of the combination, especially for children, must be established by a qualified healthcare professional in accordance with the approved product information.

TEMPERATE-SPAS is a branded formulation from Amcare Pharmaceuticals. The following information is organised for pharmaceutical product catalogues, website listings, distributor references and product documentation.

2. Product Composition and Specifications

The composition below is transcribed from the supplied product artwork.

Parameter Product information
Brand name TEMPERATE-SPAS
Generic name Dicyclomine Hydrochloride and Paracetamol Suspension
Paracetamol IP 125 mg per 5 mL
Dicyclomine Hydrochloride IP 10 mg per 5 mL
Flavoured syrup base Q.S.
Dosage form Oral suspension
Flavour Strawberry
Route of administration Oral
Therapeutic category Antispasmodic and analgesic
Company Amcare Pharmaceuticals
Pack volume Confirm from the approved marketed pack

Important: The supplied artwork does not clearly establish the total bottle volume. Confirm the marketed pack size, complete excipient list and approved product particulars before publishing commercial specifications.

3. Understanding the Active Ingredients

A. Dicyclomine Hydrochloride IP – 10 mg per 5 mL

Dicyclomine Hydrochloride is an anticholinergic antispasmodic medicine. It reduces the effect of acetylcholine on certain muscarinic receptors, helping relax smooth muscle and relieve spasms in the gastrointestinal tract.

Smooth muscle contractions contribute to the movement of intestinal contents. Excessive or painful contractions can be associated with abdominal cramping and discomfort. By reducing these contractions, Dicyclomine may help relieve spasmodic abdominal pain in appropriately selected patients.

Pharmacological role of Dicyclomine Hydrochloride:

  • Helps relieve selected types of gastrointestinal smooth muscle spasm.
  • May reduce abdominal cramping associated with conditions for which antispasmodic treatment is appropriate.
  • Acts through anticholinergic mechanisms.
  • Helps reduce spasmodic discomfort when prescribed for a suitable indication.

Dicyclomine is not appropriate for every cause of abdominal pain. It can produce anticholinergic adverse effects, including dry mouth, blurred vision, constipation, dizziness and difficulty passing urine.

It must not be administered to infants younger than six months. Serious respiratory and neurological reactions have been reported in this age group. Particular caution is also necessary in children and in patients with certain gastrointestinal, urinary, cardiac or eye conditions.

B. Paracetamol IP – 125 mg per 5 mL

Paracetamol, also known as acetaminophen, is an analgesic and antipyretic medicine. It acts primarily through mechanisms within the central nervous system to reduce pain perception and help regulate elevated body temperature.

Unlike conventional non-steroidal anti-inflammatory drugs, Paracetamol has relatively limited peripheral anti-inflammatory activity at therapeutic doses.

Pharmacological role of Paracetamol:

  • Helps relieve selected types of mild to moderate pain.
  • Helps reduce elevated body temperature.
  • May relieve discomfort associated with certain acute illnesses.
  • Provides analgesic activity alongside the antispasmodic action of Dicyclomine.

Correct dosing is essential because excessive Paracetamol exposure can cause severe liver injury. Patients should avoid inadvertently taking additional medicines containing Paracetamol.

C. Flavoured Syrup Base – Q.S.

The syrup base serves as the vehicle for the active pharmaceutical ingredients and provides the formulation with its liquid consistency. The supplied artwork identifies strawberry as the flavour.

The exact excipients, sweeteners, preservatives and sugar content should be confirmed from the approved product formulation and package insert.

4. Therapeutic Uses of TEMPERATE-SPAS Suspension

TEMPERATE-SPAS combines an antispasmodic agent with an analgesic and antipyretic medicine. Its potential role depends on the underlying cause of the patient’s symptoms and the approved indications for the marketed formulation.

A. Abdominal Cramps and Spasmodic Pain

Dicyclomine Hydrochloride helps relax gastrointestinal smooth muscle and may relieve abdominal cramping associated with selected conditions involving intestinal spasms.

The suitability of treatment depends on the nature, severity and duration of the pain. Severe, persistent or unexplained abdominal pain requires medical assessment rather than automatic treatment with an antispasmodic.

B. Gastrointestinal Smooth Muscle Spasms

The antispasmodic action of Dicyclomine may help reduce discomfort associated with certain gastrointestinal spasmodic conditions when prescribed by a healthcare professional.

Not every cause of abdominal discomfort is related to smooth muscle spasms. Infections, inflammation, obstruction and other abdominal conditions may require different treatment.

C. Pain Relief

Paracetamol helps relieve selected types of pain. In this combination, its analgesic action complements the antispasmodic activity of Dicyclomine.

The product should be used only when both ingredients are considered appropriate for the patient’s condition.

D. Discomfort Associated with Acute Illness

Certain illnesses can be accompanied by abdominal discomfort or pain. However, the presence of abdominal pain does not establish that an antispasmodic combination is appropriate.

A healthcare professional should evaluate symptoms such as persistent vomiting, abdominal swelling, blood in stools, severe tenderness or significant dehydration before treatment.

E. Fever

Paracetamol has antipyretic properties and can help reduce elevated body temperature. However, TEMPERATE-SPAS should not automatically be selected as a general fever medicine because it also contains Dicyclomine, which may be unnecessary or unsuitable for the patient.

Clinical limitation: These are pharmacological roles associated with the active ingredients, not confirmation that every indication is approved for TEMPERATE-SPAS. Verify the approved prescribing information before making therapeutic claims in marketing materials.

5. Mechanism of Action

TEMPERATE-SPAS contains two active pharmaceutical ingredients with different pharmacological actions.

Dicyclomine Hydrochloride: Antispasmodic Action

Dicyclomine acts primarily as an antimuscarinic agent. It reduces the effect of acetylcholine on muscarinic receptors involved in smooth muscle contraction.

This action can contribute to:

  • Relaxation of gastrointestinal smooth muscle.
  • Reduction of selected intestinal spasms.
  • Relief of cramping associated with appropriate gastrointestinal conditions.

Its anticholinergic action also explains potential adverse effects such as dry mouth, blurred vision, constipation and urinary retention.

Paracetamol: Analgesic and Antipyretic Action

Paracetamol acts predominantly through central mechanisms involved in pain processing and temperature regulation.

Its principal effects include:

  • Reducing pain perception.
  • Helping lower elevated body temperature.
  • Providing analgesia through a mechanism different from the antispasmodic action of Dicyclomine.

Paracetamol does not have the same degree of peripheral anti-inflammatory activity as conventional NSAIDs.

Combined Action of TEMPERATE-SPAS

When both ingredients are appropriate for the diagnosed condition, the combination provides antispasmodic activity alongside pain relief.

However, the combination does not eliminate the individual risks associated with either ingredient. The clinical suitability of the product must be assessed carefully, particularly for paediatric patients.

6. Key Product Benefits and Highlights

TEMPERATE-SPAS has several formulation characteristics relevant to pharmaceutical product documentation.

  • Dual-ingredient formulation: Contains Dicyclomine Hydrochloride and Paracetamol in one oral suspension.
  • Antispasmodic component: Dicyclomine helps relieve selected gastrointestinal smooth muscle spasms.
  • Analgesic component: Paracetamol provides pain-relieving activity.
  • Defined composition: Each 5 mL contains Dicyclomine Hydrochloride 10 mg and Paracetamol 125 mg, according to the supplied artwork.
  • Liquid dosage form: Available as an oral suspension rather than a solid oral dosage form.
  • Strawberry flavour: The flavoured syrup base is intended to improve palatability.
  • Oral administration: Designed for administration by mouth according to approved directions.
  • Branded pharmaceutical presentation: The supplied artwork identifies the product as TEMPERATE-SPAS from Amcare Pharmaceuticals.

These points describe the formulation and its pharmacological characteristics. They do not establish clinical superiority, faster action or better tolerability compared with other products.

7. Dosage and Administration

The dose of TEMPERATE-SPAS must be determined by a qualified healthcare professional using the patient’s age, body weight, symptoms, medical history and the approved product information.

This is particularly important because the formulation combines two medicines with different dosing requirements and safety considerations.

Important paediatric restriction: Dicyclomine must not be used in infants younger than six months. Do not assume that this combination is suitable for every child with abdominal pain, cramps or fever.

General Administration Guidance

  1. Shake the bottle as directed on the approved product label.
  2. Measure the prescribed quantity using a calibrated oral syringe or appropriate medicine-measuring device.
  3. Avoid household teaspoons because their volume can vary.
  4. Follow the prescribed frequency and duration of treatment.
  5. Do not increase the dose or shorten the interval between doses without medical advice.
  6. Check all other medicines for Paracetamol or other ingredients that could cause duplication or interactions.
  7. Follow the approved instructions for administration and storage.
  8. Seek medical assessment if symptoms persist, worsen or are accompanied by concerning signs.

Understanding the Product Strength

Active ingredient Amount in 5 mL
Paracetamol IP 125 mg
Dicyclomine Hydrochloride IP 10 mg

A prescribed volume determines the amount of both active ingredients administered together. This is important because their dosing limits, contraindications and safety considerations differ.

Do not independently calculate a child’s dose from the product strength. The healthcare professional must confirm whether the combination is appropriate and determine the correct regimen.

8. Important Safety Information and Precautions

TEMPERATE-SPAS requires particular caution because it contains an anticholinergic medicine as well as Paracetamol.

A. Use in Infants and Children

Dicyclomine is contraindicated in infants younger than six months. Serious respiratory symptoms and other severe adverse reactions have been reported in this age group.

For older children, the suitability of this combination must be assessed according to the approved product information and individual clinical circumstances.

B. Gastrointestinal Conditions

Dicyclomine may be unsuitable in patients with obstructive gastrointestinal conditions, including certain cases of intestinal obstruction or severe gastrointestinal motility disorders.

Seek medical assessment for severe abdominal pain, marked abdominal swelling, persistent vomiting, blood in stools or an inability to pass stool or gas.

C. Anticholinergic Effects

Dicyclomine may cause:

  • Dry mouth.
  • Blurred vision.
  • Constipation.
  • Dizziness or drowsiness.
  • Difficulty passing urine.
  • Reduced sweating and overheating in susceptible patients.
  • Increased heart rate in some patients.

Patients should seek medical advice if these symptoms are significant or persistent.

D. Liver Safety

Excessive Paracetamol exposure can cause severe liver injury. Early symptoms of overdose may be mild or absent.

Avoid combining TEMPERATE-SPAS with other Paracetamol-containing medicines unless a healthcare professional has reviewed the total exposure. Patients with liver disease or other relevant risk factors require individual assessment.

E. Kidney and Urinary Conditions

Patients with kidney disease or difficulty passing urine should receive appropriate medical assessment before using the product. Dicyclomine’s anticholinergic effects may aggravate urinary retention in susceptible individuals.

F. Eye Conditions

Dicyclomine may be unsuitable for patients with certain forms of glaucoma because its anticholinergic effects can increase intraocular pressure.

G. Cardiovascular Conditions

Dicyclomine may increase heart rate and requires caution in patients with certain cardiac conditions. The healthcare professional should review the patient’s medical history before prescribing the combination.

H. Pregnancy and Breastfeeding

The suitability of Dicyclomine and Paracetamol during pregnancy or breastfeeding should be assessed by a healthcare professional. Do not assume that the combination is appropriate simply because one of its ingredients may be used in selected circumstances.

I. When to Seek Urgent Medical Attention

Seek urgent medical help for:

  • Difficulty breathing or swelling of the face, lips or throat.
  • Severe or rapidly worsening abdominal pain.
  • Marked abdominal swelling with persistent vomiting.
  • Severe confusion, fainting or unusual neurological symptoms.
  • Inability to pass urine.
  • Suspected overdose of either ingredient.
  • Signs of severe allergic reaction or other serious adverse effects.

In a suspected Paracetamol overdose, do not wait for symptoms to appear before seeking emergency assessment.

9. Possible Side Effects of TEMPERATE-SPAS Suspension

Not every patient experiences adverse effects. The potential reactions depend on the ingredients, dose, treatment duration and the patient’s medical history.

Body system Possible adverse effects
Gastrointestinal Nausea, abdominal discomfort, constipation and other digestive symptoms
Mouth and throat Dry mouth
Eyes Blurred vision and difficulty focusing
Nervous system Dizziness, drowsiness, confusion or other neurological symptoms
Urinary system Difficulty passing urine or urinary retention
Cardiovascular system Increased heart rate or palpitations
Skin Rash, itching or other allergic reactions
Liver Liver injury associated with excessive Paracetamol exposure or other risk factors
Temperature regulation Reduced sweating and overheating in susceptible patients
Allergic reactions Wheezing, facial swelling or breathing difficulty in susceptible individuals

This table is not an exhaustive list of possible adverse reactions.

If a serious reaction is suspected, discontinue further administration and obtain urgent medical assessment. Suspected overdose requires immediate medical attention, even when the patient initially appears well.

10. Drug Interactions

Before TEMPERATE-SPAS is prescribed, the healthcare professional or pharmacist should review the patient’s other medicines and relevant medical conditions.

Medicines Requiring Particular Attention

1. Other Paracetamol-containing medicines

Taking additional Paracetamol products may result in excessive total exposure and increase the risk of liver injury.

2. Anticholinergic medicines

Other medicines with anticholinergic effects may increase the risk of dry mouth, constipation, blurred vision, urinary retention, confusion and other adverse effects when combined with Dicyclomine.

3. Medicines affecting gastrointestinal motility

Some medicines that influence intestinal movement may interact pharmacologically with Dicyclomine. The combination requires appropriate clinical review.

4. Certain antihistamines

Some antihistamines have anticholinergic properties and may increase adverse effects when used with Dicyclomine.

5. Tricyclic antidepressants

Certain tricyclic antidepressants have anticholinergic effects and may increase the risk of related adverse reactions when taken with Dicyclomine.

6. Alcohol and sedating medicines

Alcohol and certain sedating medicines may increase concerns about dizziness, drowsiness or impaired alertness. Patients should obtain appropriate advice about their specific medicines.

7. Other prescription medicines

Patients should disclose all prescription medicines, over-the-counter products and supplements to their healthcare professional. This is particularly important for patients with chronic medical conditions or those receiving multiple medicines.

Do not start or stop a prescribed medicine solely on the basis of this general interaction list.

11. Storage and Handling

TEMPERATE-SPAS should be stored according to the approved product label and package insert.

Recommended general precautions include:

  • Keep the bottle tightly closed when not in use.
  • Protect the product from excessive heat and direct sunlight.
  • Store it at the temperature specified on the approved label.
  • Keep the medicine out of the reach and sight of children.
  • Check the expiry date before administration.
  • Follow the manufacturer’s directions concerning use after opening.
  • Do not use the product if the bottle is damaged or the suspension shows an unexpected change in appearance.

The exact storage temperature, shelf life and in-use period must be confirmed from the approved product information.

12. Packaging and Commercial Product Information

The supplied TEMPERATE-SPAS artwork shows brown medicine bottles with printed labels and golden-coloured caps. The labels feature a light aqua background with contrasting dark text and red branding accents. A strawberry graphic identifies the flavour.

The supplied visual is suitable as a reference for pharmaceutical product catalogue and distributor documentation.

Packaging parameter Details
Brand name TEMPERATE-SPAS
Product type Oral suspension
Primary packaging Bottle
Label design Light aqua background with dark text and red brand accents
Flavour identification Strawberry
Paracetamol strength 125 mg per 5 mL
Dicyclomine Hydrochloride strength 10 mg per 5 mL
Secondary packaging Confirm against the marketed pack
Pack volume Verify from the actual product label
Company branding Amcare Pharmaceuticals

Before publishing the product commercially, ensure that the composition, dosage form, bottle volume, manufacturing and marketing particulars, licence details, batch information, expiry date, warnings and approved claims are consistent with the actual product label.

TEMPERATE-SPAS Suspension | Composition & Product Details

59, Tulsi Estate & Plaza,
Besides Changodar Bridge, Changodar, Ahmedabad-382213.

+91 99139 17125

info.amcerebiosciences@gmail.com

Get in touch with us